Atreo.io develop an RTSM solution in the market, revolutionizing the client experience.
Atreo.io develop an RTSM solution in the market, revolutionizing the client experience.Atreo’s team has diverse and complementary experience across all aspects of RTSM, Clinical Supplies, and Clinical Trials project delivery and support. Atreo’s team has delivered and supported 1000+ clinical trials for a diverse client pool including emerging Biotechs to top 10 Pharma and CROs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 6, 2022 | Pre-seed | $4M | 3 | Jon Dole | — | Detail |
May 7, 2021 | Pre-seed | $1.75M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Jon Dole | Yes | Pre-seed |
Cal Henderson | — | Pre-seed |
Stewart Butterfield | — | Pre-seed |